Interim report January–March 2007

• Net sales totaled 33.3(64.4) MSEK.
• Operating profit totaled -10.7 (-4.2) MSEK.
• Result after tax totaled -11.1 (-3.1) MSEK.
• Earnings per share totaled -0.54 (-0.21) MSEK.
• The result for 2007 will be negative, however, better than the result for 2006 excluding write-downs of a one-time character.

Important events after the reporting period
Ortivus receives a first order within the frame-work for the British, NHS Connecting for Health program, of 14 MSEK.


Summary of the first quarter 2007
During the first quarter, further development for MobiMed ePR (electronic patient record) within the framework for actions in regard to the NHS Connecting for Health program entered its final phase. For CoroNet, the work has focused on function and quality assurance, including necessary adaptations for internationalization. This work is expected to be concluded in the second quarter. Restructuring of the German subsidiary has been concluded. However, certain costs will also impact the second quarter. In Germany, there are signs of a stabilization of the market situation. However, the price situation is assessed to continue to remain low.


Future reporting dates:
Interim report January-June will be published on August 20
Interim report January-September will be published on November 12

For more information:
Mikael Strindlund, CEO, Telephone: + 46 8 446 4503, Cell phone: +46 70 269 5303
E-mail: firstname.lastname@ortivus.com
Per Bourn, CFO, Telephone: +46 446 4502, Cell phone: +46 733 33 99 90
E-mail: firstname.lastname@ortivus.com

Also visit www.ortivus.com